Clinical trial of fusidic acid for lepromatous leprosy.

Fusidic acid was assessed for antileprosy activity in nine lepromatous leprosy patients. Patients received fusidic acid at either 500 mg/day for 12 weeks or 750 mg/day for 4 weeks followed by 500 mg/day for 8 weeks. All patients showed time-dependent clinical improvement and decreases in bacillary m...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Antimicrob Agents Chemother
Hauptverfasser: Franzblau, S G, Chan, G P, Garcia-Ignacio, B G, Chavez, V E, Livelo, J B, Jimenez, C L, Parrilla, M L, Calvo, R F, Williams, D L, Gillis, T P
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society for Microbiology (ASM) 1994
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC284609/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7979302/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.38.7.1651
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge